As part of the 2013 Oil & Gas Finance Forum, MiNE LLC is pleased to announce distinguished guest speaker ValuEngine Chief Market Strategist Richard Suttmeier Full article (HTML) | E-mail | Print
Vocera Communications Inc. provides mobile communication solutions focused on addressing critical communication challenges facing hospitals. Vocera was the Tech sector pick for our VE Forecast 16 Market Neutral Newsletter for this month.Since our rebalance last week, Vocera has jumped up nicely and is up more than 18%. Full article (HTML) | E-mail | Print
Strong markets have meant very strong performance from our various long portfolios and the long-side of our VE Forecast 16 Market Neutral Strategy. We re-balanced the VE Forecast MNS yesterday and the longs were excellent. We called the allocation perfectly for the month with our suggested long-bias. Our long side more than doubled the S&P 500 return with an impressive gain in excess of 12%. Full article (HTML) | E-mail | Print
Our models find that overvaluation is at levels typically seen when market pullbacks occur. Overvalued stocks now make up almost 66% of our universe and 26.5% of the universe is calculated to be overvalued by 20% or more.?15 of 16 sectors are calculated to be overvalued. Full article (HTML) | E-mail | Print
As part of the 2013 Oil & Gas Finance Forum, MiNE LLC is pleased to announce distinguished guest speaker ValuEngine Chief Market Strategist Richard Suttmeier. Hear his thoughts and be part of the discussion of current market conditions drivers, the new economy in natural gas, and challenges for development and growth of the oil & gas industry.
Full article (HTML) | E-mail | Print
YOU ARE INVITED TO A FREE INVESTMENT PRESENTATION
TONIGHT IN TAMPA. VE's Chief Market Strategist Richard Suttmeier will be presenting investment advice and analysis to the University of Tampa Investment Club. Full article (HTML) | E-mail | Print
Please join us in Tampa on April 29th for a special presentation on investment strategies and the market outlook for 2013 from our Chief Market Strategist Richard Suttmeier. Full article (HTML) | E-mail | Print
Raptor is a pharmaceutical pick for our VE Small Cap Stock newsletter.Since our rebalance last week, Raptor is up more than twelve percent.Raptor is on the move because it has an important drug in the pipeline--Procysbi--which may garner FDA approval at the end of the month. Full article (HTML) | E-mail | Print
JinkoSolar has been a short favorite of our models for a while now. It was the short pick for our VE Forecast 16 MNS newsletter for March/April.?The stock has been declining and thus as a short selection it is performing as expected.?Currently, the return is @38% and the pick leads our short-side portfolio. Full article (HTML) | E-mail | Print
Repros Therapeutics was a favorite of our models over the past few months and was a selection for several of our newsletters at their most recent rebalances a few weeks ago.?The company released some good test results from a new testosterone drug called "Androxal" on Wednesday after the close and since then the stock has shot up in price.?Currently, our gain sits at @60%. Full article (HTML) | E-mail | Print
